Craig Hopkinson Named to the 2024 PharmaVoice 100

We're proud to share that Craig Hopkinson, M.D., our Executive Vice President, Research & Development and Chief Medical Officer was named to the 2024 PharmaVoice 100, an annual recognition of 100 honorees from across the biopharmaceutical industry whose individual contributions are shaping the future of our sector. Named a "Trailblazer," this award recognizes Craig's commitment to patients and his leadership of our R&D organization.
Read Craig's Profile